Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome

Hormone and Metabolic Research

Volumn 43, Issue 9, 2011, Pages 607-613

  Karamouzis, I ^a   Pervanidou, P ^a   Berardelli, R ^b   Iliadis, S ^c   Papassotiriou, I ^d   Karamouzis, M ^c   Chrousos, G P ^a   Kanaka Gantenbein, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF TURIN   (Italy)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

antioxidant state; carbonyl proteins; isoprostane; pediatric obesity; thromboxane

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CARBONYL DERIVATIVE; ISOPROSTANE; THROMBOXANE B2;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; METABOLISM; OXIDATIVE STRESS; PREPUBERTY; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE ACTIVATION;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHILD; DOWN-REGULATION; HUMANS; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PLATELET ACTIVATION; PUBERTY; UP-REGULATION;

EID: 80051718850     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1284355     Document Type: Article

References (62)

1. Haffner SM. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med: 2006; 119 05 S3 S9
2. Isomaa B, Almgren P, Tuomi T, Forsn B, Lahti K, Nissn M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care: 2001; 24 683 689 (Pubitemid 32893993)
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA: 2002; 288 2709 2716 (Pubitemid 35403784)
4. Sattar N, Gaw A, Scherbakova O, Ford I, OReilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation: 2003; 108 414 419 (Pubitemid 36935533)
5. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation: 2004; 110 1251 1257 (Pubitemid 39202341)
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA: 2001; 285 2486 2497
7. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med: 1999; 16 442 443
8. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med: 2006; 23 469 480
9. World Health Organization Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation part 1: diagnosis and classification of diabetes mellitus, Geneva,: 1999; 59
10. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet: 2005; 365 9468 1415 1428 (Pubitemid 40523737)
11. World Health Organization Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser: 2000; 894 ixii 1 253
12. Lobstein T, Baur L, Uauy R. IASO International Obesity Task Force. Obesity in children and young people: a crisis in public heath. Obes Rev: 2004; 5 01 4 104 (Pubitemid 38967209)
13. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes: 2006; 1 11 25
14. Hayden MR, Whaley-Connell A, Sowers JR. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. Am J Nephrol: 2005; 25 553 569 (Pubitemid 41819029)
15. Knight JA. Free Radicals: their presence in biological system. In: Free Radicals, Antioxidants, Aging, and Disease. Washington AACC Press: 1999; 21 43
16. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol: 2007; 39 44 84 (Pubitemid 44566469)
17. Davi G, Falco A. Oxidant stress, inflammation and atherogenesis. Lupus: 2005; 14 760 764 (Pubitemid 41413307)
18. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol: 2008; 28 397 404 (Pubitemid 351501605)
19. Karamouzis I, Grekas D, Karamouzis M, Triantos A, Vasileva-Staikova S, Kovachev D, Dimitriadou A. Enhanced oxidative stress with gradient between plasma and muscle interstitial fluid in patients with end stage renal failure on hemodialysis. Hormones (Athens): 2008; 7 62 69
20. Karamouzis I, Grekas D, Karamouzis M, Kallaras K, Stergiou-Michailidou V, Kouidi E, Deligiannis A, Vavatsi-Christaki N. Physical training in patients on hemodialysis has a beneficial effect on the levels of eicosanoid hormone-like substances. Hormones (Athens): 2009; 8 129 137
21. Giannini C, De Giorgis T, Scarinci A, Cataldo I, Marcovecchio ML, Chiarelli F, Mohn A. Increased carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: the speculative role of insulin sensitivity, oxidant status, and chronic inflammation. Eur J Endocrinol: 2009; 161 73 80
22. Kaufman CL, Kaiser DR, Steinberger J, Kelly AS, Dengel DR. Relationships of cardiac autonomic function with metabolic abnormalities in childhood obesity. Obesity: 2007; 15 1164 1171 (Pubitemid 46932471)
23. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab: 2003; 88 4673 4676 (Pubitemid 37357510)
24. Kelly AS, Steinberger J, Kaiser DR, Olson TP, Bank AJ, Dengel DR. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr: 2006; 1 248 252
25. Basili S, Pacini G, Guagnano MT, Manigrasso MR, Santilli F, Pettinella C, Ciabattoni G, Patrono C, Dav G. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol: 2006; 48 2531 2538 (Pubitemid 44881227)
26. Dav G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA: 2002; 288 2008 2014 (Pubitemid 35204691)
27. Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med: 2000; 28 505 513 (Pubitemid 30136031)
28. Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol: 2005; 25 279 286 (Pubitemid 40189146)
29. Morrow JD, Hill E, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in human by non-cycloxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA: 1990; 87 9383 9387 (Pubitemid 120030630)
30. Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem: 1999; 274 24441 24444
31. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci: 2002; 23 360 366
32. Pratico D, Lawson JA, FitzGerald GA. Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha. J Biol Chem: 1995; 270 9800 9808
33. Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, FitzGerald GA. The isoprostanes: a perspective. Prostaglandins: 1997; 54 823 851 (Pubitemid 28124311)
34. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: Markers and mediators of oxidative stress. FASEB J: 2004; 8 1791 1800 (Pubitemid 39602265)
35. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of protein. Physiological consequences. J Biol Chem: 1991; 266 2005 2008 (Pubitemid 21909019)
36. Nakahata N. Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther: 2008; 118 18 35
37. Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. J Biol Chem: 1996; 271 23185 23190 (Pubitemid 26314756)
38. Van Kraaij DJ, Hovestad-Witterland AHI, de Metz M, Vollaard EJ. A comparison of the effects of nabumetone vs. meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. Br J Clin Pharmacol: 2002; 53 644 647 (Pubitemid 34621791)
39. Katugampola SD, Davenport AP. Thromboxane receptor density is increased in human cadiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br J Pharmacol: 2001; 134 1385 1392 (Pubitemid 33131888)
40. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V. High glucose causes upregulation of cycloxygenase-2 and alters prostanoid profile in human endothelial cells. Circulation: 2003; 107 1017 1023
41. Dogn JM, Hanson J, Pratico D. Thromboxane prostacyclin and isoprostanes: therapeutic targets in atherogenesis. Trends Pharmacol Sci: 2005; 26 639 644 (Pubitemid 41636309)
42. Mohn A, Catino M, Capanna R, Giannini C, Marcovecchio M, Chiarelli F. Increased oxidative stress in prepubertal severely obese children: effect of a dietary restriction-weight loss program. J Clin Endocrinol Metab: 2005; 90 2653 2658 (Pubitemid 40686305)
43. Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr. Alfa-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation: 1996; 94 2434 2440 (Pubitemid 26403570)
44. Koh KK, Oh PC, Quon MJ. Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res: 2009; 81 649 659
45. Jialal I, Fuller CJ, Huet BA. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol: 1995; 15 190 198
46. Miller NJ, Rice-Evans C. Factors influencing the antioxidant activity determined by the ABTS+ radical cation assay. Free Rad: 1997; 26 195 199 (Pubitemid 27187035)
47. Nourooz-Zadeh J, Ziegler D, Sohr C, Betteridge JD, Knight J, Hothersall J. The use of Pholasin as a probe for the determination of plasma total antioxidant capacity. Clin Biochem: 2006; 39 55 61
48. Tinahones FJ, Murri-Pierri M, Garrido-Snchez L, Garca-Almeida JM, Garca-Serrano S, Garca-Arns J, Garca-Fuentes E. Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity: 2009; 17 240 246
49. Chiotis D, Krikos X, Tsiftis G, Hatzisymeaon M, Maniati-Christidi M, Dacou-Voutetakis C. Body mass index and prevalence of obesity in subjects of Hellenic origin aged 018years, living in the Athens area. Ann Clin Paediatr Univ Atheniensis: 2004; 51 139 154
50. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establising a standard definition for child overweight and obesity worldwide: international survey. BMI: 2000; 320 7244 1240 1243 (Pubitemid 30240471)
51. nd ed. Oxford Blackwell Scientific Publications: 1962
52. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. Consensus Group The metabolic syndrome in children and adolescents an IDF consensus report. Pediatr Diabetes: 2007; 8 299 306 (Pubitemid 47422902)
53. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified protein. Method Enzymol: 1994; 233 346 357
54. Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid chromatographyination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr: 1991; 572 103 116
55. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord: 2002; 26 754 764 (Pubitemid 34620866)
56. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes: 2001; 50 159 165 (Pubitemid 32047995)
57. Giannini C, De Giorgis T, Scarinci A, Ciampani M, Marcovecchio ML, Chiarelli F, Mohn A. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis: 2008; 197 448 456 (Pubitemid 351273267)
58. Codoer-Franch P, Tavrez-Alonso S, Murria-Estal R, Tortajada-Girbs M, Sim-Jord R, Alonso-Iglesias E. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children. Nutr Metab Cardiovasc Dis: 2010; Aug 12 [Epub ahead of print]
59. Strauss RS. Comparison of serum concentrations of alpha tocopherol and beta-carotene in a cross-sectional sample of obese and non obese children (NHANES III). National Health and Nutrition Examination survey. J Pediatr: 1999; 134 160 165
60. Puchau B, Ochoa MC, Zulet MA, Marti A, Martnez JA, Members G. Dietary total antioxidant capacity and obesity in children and adolescents. Int J Food Sci Nutr: 2010; 61 713 721
61. Morinobu T, Muzata T, Takaya R, Tamai H. Nutritional Status of beta-carotene, alpha-tocopherol and renitol in obese children. Int J Vitam Nutr Res: 2002; 72 119 123 (Pubitemid 34609060)
62. Codoner-Franch P, Boix-Garcia L, Sim-Jord R, Del Castillo-Villaescusa C, Maset-Maldonado J, Valls-Belles V. Is obesity associated with oxidative stress in children? Int J Pediatr Obes: 2010; 5 56 63